In MS, CXCL13 has been shown to be upregulated in active lesions6 but also in tertiary lymphoid structures in the meninges.7 It is established as a biomarker of neuroborreliosis8 but has also been investigated as a biomarker of MS on several occasions. The gene discussed is CXCL13; the disease is myeloid sarcoma.